About Baruch Lieber
Form D filings for IOP Diagnostics in 2024 list Baruch Lieber as president and director.
Form D filings also name Baruch Lieber as a president & CSO at Prometheus Therapeutics and sits on its board.
Baruch Lieber first appears on SEC filings in 2020.
Experience
This experience comes from Baruch Lieber's profile and from SEC filings. For roles taken from filings, the years are when the filings name Baruch Lieber in the role, so the role may have started earlier or lasted longer.
IOP Diagnostics, Inc. Current
Co-Founder & President (2022 – Present)
Director
2022 – Present · Forest Hill, NY
Prometheus Therapeutics Inc. Current
President & CSO, director
Co-Founder President & Chief Scientific officer (2014 – Present)
2014 – Present · Miramar, FL
Develops light-based treatment technology for people with vascular diseases, including brain aneurysms.
SU
Stony Brook University Current
Proferrsor of neurosurgery (Retired)
2009 – Present
TM
Tufts University School of Medicine
Professor of Radiology
2018 – 2023
VI
Vascular Simulations, Inc.
Co-Founder & Chairman of The Board
2011 – 2020
SL
Surpass Medical LTD
Co-Founder & Shief Scientific Officer
2005 – 2012
UM
University of Miami
Professor of Bioengeering and Radiology
2001 – 2009
UB
University at Buffalo
Professor of Mechanical and Aerospace Engineering, Director Bioengineering Center
1987 – 2001
Key Colleagues at Startups
The people Baruch Lieber works with at each company, as listed on that company's latest Form D.
Prometheus Therapeutics Inc. · Form D/A, Apr 15, 2026
AH
Alexander Hastings
Director
BN
Bernie Navarro
Executive officer
Ajay Wakhloo
CEO and director
JM
John McEleney
Director
IOP Diagnostics, Inc. · Form D, Nov 7, 2024